EMDG.L $689.20 0.8192%
FIZZ $51.49 -0.5697%
IGSG.L $4 594.50 0.1744%
TIOAW $0.00 0%
AFINO $25.66 0%
CORR $1.07 -1.037%
GRNVW $1.20 0%
LFMDP $15.70 -0.2985%
CCBO.L $74.00 -0.135%
SPBO $29.02 -0.3776%
RBLD $49.42 -0.9478%
0R9H.L $1.35 0%
PFES $62.10 2.8299%
HFD.L $198.60 -0.0503%
SHAC $10.08 0%
8020.HK $0.01 0%
0LIU.L $44.64 -0.439%
FT $6.73 -0.138%
CBTX $29.25 0%
0QSV.L $7.98 -0.4803%
ECPG $44.76 -1.0939%
FLNT $0.76 0.8878%
0VQA.L $22.08 -4.053%
AFMD $0.86 -5.8303%
UMH $15.81 0.031%
VIS.MC $64.80 0.4651%
NTST $17.94 -0.4992%
SPDW $32.59 -0.5038%
MVBF $16.84 -1.7795%
CI2.PA $704.30 0.6311%
PL $4.10 0.8621%
RYH $291.48 -0.3371%
RSE.L $550.00 -1.4337%
SPNE $9.54 0%
SSNT $3.01 1.1765%
FKE.L $67.50 0%
STSA $1.06 -0.9346%
USEA $2.76 -2.1312%
Q5T.SI $0.60 -2.459%
PSL $87.23 0.2644%
DXJG.L $1 824.28 0.4142%
FNY $58.63 -0.3361%
TGB $1.44 -1.0345%
BLFY $8.70 -0.5714%
APCXW $0.41 5.4771%
1672.HK $2.50 -4.5801%
BENE $10.44 0%
LCOP.L $7.23 1.2244%
2148.HK $3.60 1.983%
SPKEP $25.96 0%
ATHA $2.93 -0.678%
1861.HK $1.53 0%
ARDX $4.27 -0.4662%
8087.HK $0.20 0%
0JU0.L $112.95 -1.5644%
DEMZ $24.93 -0.479%
DCI.L $3.70 -2.6316%
JPSE $37.95 -0.6579%
FRAS.L $777.00 -0.5122%
0R2J.L $79.89 0.4152%
0HF7.L $145.23 0.7541%
FJP $46.06 -0.3677%
NEWA $4.17 0%
RAACU $9.91 0%
MFT.NZ $70.00 0.5747%
0IWU.L $15.90 -0.625%
ME $2.02 -4.0476%
1033.HK $0.64 0%
2377.HK $0.98 4.2553%
7230.HK $1.85 0%
8418.HK $0.91 -1.087%
MTVC $10.49 0%
8079.HK $0.17 -5.0279%
LFI.L $39.94 3.7403%
APA $32.71 -1.1185%
DIE.BR $164.90 -1.0798%
BPYU $18.52 0%
3678.HK $1.80 -0.5525%
1057.HK $1.50 -1.3158%
KVLE $22.03 -0.0553%
KDR.L $2.42 -10.2593%
DDIV $27.16 0.1146%
TUP $0.70 -7.8361%
3606.HK $31.40 -1.2579%
SSAC.L $5 351.00 0.1779%
GLTO $2.01 0%
ALRPD.PA $0.00 0%
FEP $34.52 -0.3046%
TIGO $17.83 -2.0467%
SVM $3.45 0.1453%
MOHO $0.10 0%
HWKZ $10.25 0.1965%
GLYC $1.89 8.8391%
0288.HK $4.21 -1.1737%
0828.HK $0.23 -1.2931%
LFLYW $0.06 56.6951%
8056.HK $0.33 -1.5152%
RBT.PA $875.00 -0.2281%
ARV.NZ $1.05 0.9615%
Eng
Логотип
Eng
Лого

Brooklyn ImmunoTherapeutics, Inc. BTX

$0.21

На 18:01, 12 мая 2023

Ранг: 3

Ранг - это оценка кредитоспособности корпорации.

Ключевые показатели

  • Marketcap

    1051562.00000000

  • week52high

    200.00

  • week52low

    0.18

  • Revenue

    0

  • P/E TTM

    0

  • Beta

    0.78748000

  • EPS

    -2.82500000

  • Last Dividend

    0.00000000

  • Next Earnings Date

    09 ноя 2022 г. в 01:14

Описание компании

Brooklyn ImmunoTherapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing therapies to treat patients with cancer. Its advanced program is IRX-2 that is in a Phase 2b clinical trial in patients with squamous cell cancer of the head and neck. The company also develops therapies using gene-editing and cell therapy technology for the treatment of oncology, blood disorder, and monogenic disease. Brooklyn ImmunoTherapeutics, Inc. is based in Brooklyn, New York.

Рекомендации
аналитиков

Рекомендации аналитиков — понятие, что это такое и как.
Grading company New grade Previous grade Recommendation date
Cantor Fitzgerald Overweight 29 дек 2021 г.
Raymond James Outperform Outperform 18 мар 2019 г.
H.C. Wainwright Buy 21 февр 2019 г.
Maxim Group Buy 24 янв 2019 г.
Oppenheimer Outperform 11 дек 2018 г.
Maxim Group Hold Buy 12 окт 2022 г.

Свежие комментарии

Оставьте свой голос

Анонимное голосование

Будет ли рост российского рынка к концу года?

  • Да

    87%

  • Нет

    12%

Проголосовал 8 человек

Insider Summary

Reporting Name Acquistion/Disposition Owned Transacted Transaction Date
Sidhu Roger D 60487 20163 20 сент 2022 г.
Sidhu Roger A 20163 20163 20 сент 2022 г.
Singer Nicholas Jason A 165800 165800 01 авг 2022 г.
Singer Nicholas Jason A 146100 146100 01 авг 2022 г.
Fiore Gregory A 165800 165800 01 авг 2022 г.
Fiore Gregory A 95100 95100 01 авг 2022 г.
Cherington Charles A 165800 165800 01 авг 2022 г.
Cherington Charles A 215100 215100 01 авг 2022 г.
Angel Matthew A 2487003 2487003 01 авг 2022 г.
Wexler William A. A 165800 165800 01 авг 2022 г.